Reference
Wang H, et al. Ultra-low-dose decitabine combined with autologous cytokine-induced killer cells for elderly patients with acute myeloid leukemia transformed from myelodysplastic syndrome. Clinical Therapeutics 36: 1104-1111, No. 7, Jul 2014. Available from: URL: http://doi.org/10.1016/j.clinthera.2014.05.065 - China
Rights and permissions
About this article
Cite this article
Aldesleukin/cytokine-induced killer cell therapy/decitabine. Reactions Weekly 1515, 20 (2014). https://doi.org/10.1007/s40278-014-2715-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-2715-3